Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation

Recruiting now · Phase 4

Conditions studied: Antiplatelet Agents, Perioperative Care

In brief

The purpose of this study is to evaluate the impact of perioperative aspirin continuation on clinical outcomes in patients with a history of coronary stent implantation who are scheduled for abdominal surgery.

Key facts

Study ID

NCT06723145

Run by

Kyoto University

People needed

1200

Starts

2025-01-20

Expected to finish

2027-03-31

Last updated by the study team

2025-02-11

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a history of coronary stenting and scheduled for abdominal surgery
• Patients on a single antiplatelet agent

You may not qualify if…

• Patients on dual antiplatelet therapy (DAPT)
• Patients on anticoagulation therapy
• Patients with a history of stent thrombosis
• Patients with CHADS2 score >= 5
• Patients at extremely high risk of bleeding and unable to continue preoperative aspirin
• Patients incapable of consent, including those under 20 years of age
• Other patients for whom either discontinuation or continuation of antiplatelet agents is deemed inappropriate by the attending physician

Where it is running

• Kyoto University Hospital — Kyoto, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.